000 01354 a2200385 4500
005 20250515174336.0
264 0 _c20091019
008 200910s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.00054-09
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBulitta, J B
245 0 0 _aNew semiphysiological absorption model to assess the pharmacodynamic profile of cefuroxime axetil using nonparametric and parametric population pharmacokinetics.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cAug 2009
300 _a3462-71 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aCefuroxime
_xanalogs & derivatives
650 0 4 _aChromatography, Liquid
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aModels, Theoretical
650 0 4 _aTandem Mass Spectrometry
650 0 4 _aTime Factors
650 0 4 _aYoung Adult
700 1 _aLandersdorfer, C B
700 1 _aKinzig, M
700 1 _aHolzgrabe, U
700 1 _aSorgel, F
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 53
_gno. 8
_gp. 3462-71
856 4 0 _uhttps://doi.org/10.1128/AAC.00054-09
_zAvailable from publisher's website
999 _c18947300
_d18947300